{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BYF1",
      "entity_text" : "ACE2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "XREF_BIBR Indeed, recombinant ACE2 has been proposed as a novel therapy for PAH, to reverse vasoconstriction, proliferation, and inflammation.",
  "reading_complete" : "2020-07-28T11:48:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:48:16Z",
  "trigger" : "reverse",
  "evidence" : [ "ACE2 has been proposed as a novel therapy for PAH, to reverse vasoconstriction, proliferation, and inflammation" ],
  "pmc_id" : "7260569",
  "score" : 0
}